CLOUD-CLONE CORP. – Trademark Portfolio

Entity Type: 03

CLOUD-CLONE CORP. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CLOUD-CLONE, USCN LIFE SCIENCE INC., and USCNK LIFE SCIENCE INC.. The owner is based in Katy, TX.

23603 W. Fernhurst Drive, Unit 2201

Katy, TX 77494

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CLOUD-CLONE CORP.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CLOUD-CLONE CORP. have?

CLOUD-CLONE CORP. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does CLOUD-CLONE CORP. file in?

CLOUD-CLONE CORP. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are CLOUD-CLONE CORP.'s most well-known trademarks?

CLOUD-CLONE CORP.'s registered trademark portfolio includes well-known marks such as CLOUD-CLONE, USCN LIFE SCIENCE INC., and USCNK LIFE SCIENCE INC.. These are among 3 currently registered trademarks in the portfolio.

What is CLOUD-CLONE CORP.'s trademark registration success rate?

CLOUD-CLONE CORP. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.